Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down-regulation of Bcl-2 Expression and Modulation of Promyelocytic Leukemia Protein
スポンサーリンク
概要
- 論文の詳細を見る
- 2000-06-30
著者
-
PAN Ling
Department of Hematology, The Second Hospital of Hebei Medical University
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
FUJISAWA Shin
Yokohama City University Medical Center
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Ohno Ryuzo
Department Of Internal Medicine Iii Hamamatsu University School Of Medicine
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
NAKAO Shinji
Kanazawa University Hospital
-
AMAGASAKI Taro
Novartis Pharma Japan
-
NAITO Kensuke
The Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
TAKESHITA Akihiro
Department of Medicine III, Hamamatsu University School of Medicine
-
Shinagawa K
Okayama Univ. Hospital Okayama Jpn
-
Zhang Wen
Department Of Neurology Graduate School Of Medicine And Dentistry Okayama Univeristy
-
Naito Kensuke
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Yoshida Hitoshi
Department of Internal Medicine, Jiundo Naika Hospital
-
Shinjo Kaori
浜松医科大学 内科学第3
-
SHINJO Kaori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
NAITO Kensuke
Department of Internal Medicine, Hamamatsu University School of Medicine
-
SHIGENO Kazuyuki
Department of Internal Medicine, Hamamatsu University School of Medicine
-
NAKAMURA Satoki
Department of Internal Medicine III, Hamamatsu University School of Medicine
-
MAKSUMOVA Lola
Department of Medicine III, Hamamatsu University School of Medicine
-
MURATKHODJAEV Farkhad
Department of Medicine III, Hamamatsu University School of Medicine
-
LUO Jian
Department of Medicine III, Hamamatsu University School of Medicine
-
FUJISAWA Shinya
Department of Medicine III, Hamamatsu University School of Medicine
-
Sahara Naohi
浜松医科大学 内科学第3
-
Pan Ling
Department Of Hematology The Second Hospital Of Hebei Medical University
-
Pan Ling
Department Of Chemistry And Biochemistry Graduate School Of Engineering Kyushu University
-
Muratkhodjaev Farkhad
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Fujisawa Shinya
Department Of Hematology Hamamatsu Medical Center
-
Nakamura Satoki
県西部浜松医療センター 血液科
-
Nakamura Satoki
Department Of Internal Medicine Iii Hamamatsu University School Of Medicine
-
Maksumova Lola
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Takeshita A
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Tomida Akihiro
癌研究会癌化学療法センター
-
Shirafuji Naoki
Department Of Hematology Kanazawa University
-
Yoshida Hitoshi
Department Of Anesthesiology Hirosaki University Graduate School Of Medicine
-
Yoshida Hitoshi
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Nakao Shinji
Department Of Hematology Kanazawa University Graduate School Of Medical Science
-
Ohnishi Kazunori
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Tomita Akihiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Shigeno Kazuyuki
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Sunami K
Department Of Hematology National Hospital Organization Okayama Medical Center
-
Shinagawa Katsushi
The Second Department Of Internal Medicine
-
Shinagawa Katsuji
Department Of Biopathological Science Okayama University Graduate School Of Medicine And Dentistry
-
Shinagawa Katsuji
Division Of Hematology/oncology Okayama University Medical School
-
Nakao Shinji
Third Department Of Medicine Kanazawa University
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Zhang Wen
Department Of Chemistry East China Normal University
-
Furusawa Shinpei
Department Of Hematology Dokkyo Medical School Of Medicine
-
Furusawa Shinpei
Department Of Hematology Dokkyo University School Of Medicine
-
Ohno Ryuzo
Department Of Built Environment Tokyo Institute Of Technology
-
Ohnishi Kazunori
Department Of Dermatology Gunma University Graduate School Of Medicine
-
Luo Jian
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Furusawa S
Department Of Hematology Hamamatsu Medical Center
-
Zhang Wen
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Shirafuji Naoki
Department Of Hematology/oncology Teikyo University School Of Medicine
-
Takeshita Akihiro
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Pan Ling
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Sugiyama Katsuki
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Naito Kensuke
Department Of Hematology Hamamatsu Medical Center
-
Tamura Amane
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Ohnishi Kazunori
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
SHINJO Kaori
Department of Internal Medicine III, Hamamatsu University School of Medicine
-
SHIGENO Kazuyuki
Department of Internal Medicine III, Hamamatsu University School of Medicine
-
OHNO Ryuzo
Department of Architecture, Kobe University
関連論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFκB p65
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan